Our study revealed that intestinal-specific deletion of the corepressor NCoR1 induced robust improvements in obesity and metabolic syndrome by simultaneously decreasing the energy/lipid intake and enhancing the energy expenditure. This evidence concerns the gene NCOR1 and metabolic syndrome.